
Improving oral bioavailability of resveratrol by a UDP-glucuronosyltransferase inhibitory excipient-based self-microemulsion
Keywords: اسید آمینه غیر ضروری; ACN; acetonitrile; AP; apical; BL; basolateral; CYP450; cytochrome P450 proteins; FBS; fetal bovine serum; IC50; half-inhibitory concentration; MEM; minimum essential medium; MTT; 3-(40,50-dimethylthiazol-20-yl)-2,5-diphenyltetrazolium bromide; NEAA; none